Abbott Wins Two Scrip Awards Recognizing Excellence in Pharmaceutical and Biotech Industries
Scrip honored Abbott with two 2010 Scrip Awards for its business excellence and strong management.
"We are honored to receive these two prestigious awards on behalf of our 90,000 employees worldwide," said Miles D. White, chairman and chief executive officer, Abbott.
Abbott received awards for Pharma Company of the Year and Management Team of the Year at Scrip's sixth annual awards ceremony in London on Thursday evening. The Scrip Awards recognize excellence and achievement in the pharmaceutical and biotech industries. In 2009, Scrip recognized Mr. White as Executive of the Year.
Scrip recognized Abbott as the Pharma Company of the Year and Management Team of the Year for the company's continued strong financial performance, emerging markets strategy, new product launches and diverse pipeline.
Most read news
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Reproductive_health
Actavis divests its distribution business in Bulgaria
John_Dix_Fisher
Echis_megalocephalus
Organon Involved in Unique Initiative for the Development and Production of Biopharmaceutical Medicines

Soil bacteria as biocatalysts - Researchers have clarified the molecular structure of an enzyme class, enabling them to use bacteria to produce prodrugs
Galapagos and Arthrogen enter target discovery alliance

Time-switch for immune cells
Canadian_Deaf_Theatre
MorphoSys Signs Manufacturing Agreement with Boehringer Ingelheim
Orange_G
